Hopper JL - Search Results

1

Genetic and Environmental Causes of Variation in an Automated Breast Cancer Risk Factor Based on Mammographic Textures.

Ye Z, Dite GS, Nguyen TL, MacInnis RJ, Schmidt DF, Makalic E, Al-Qershi OM, Nguyen-Dumont T, Goudey B, Stone J, Dowty JG, Giles GG, Southey MC, Hopper JL, Li S. Ye Z, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):306-313. doi: 10.1158/1055-9965.EPI-23-1012. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38059829

2

Socioeconomic status and cancer mortality and incidence in Melbourne.

Williams J, Clifford C, Hopper J, Giles G. Williams J, et al. Eur J Cancer. 1991;27(7):917-21. doi: 10.1016/0277-5379(91)90147-6. Eur J Cancer. 1991. PMID: 1834129

3

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):413-6. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927503

4

Re: "Presenting statistical uncertainty in trends and dose-response relations".

Hopper JL, Dite GS. Hopper JL, et al. Am J Epidemiol. 2002 May 15;155(10):977-8; author reply 978-9. doi: 10.1093/aje/155.10.977. Am J Epidemiol. 2002. PMID: 11994239 No abstract available.

5

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010857

6

Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.

Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL. Giles GG, et al. Among authors: hopper jl. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):549-53. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050096

7

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.

Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C. Spurdle AB, et al. Among authors: hopper jl. Pharmacogenetics. 2002 Jul;12(5):355-66. doi: 10.1097/00008571-200207000-00003. Pharmacogenetics. 2002. PMID: 12142725

8

Heritability of mammographic density, a risk factor for breast cancer.

Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Boyd NF, et al. Among authors: hopper jl. N Engl J Med. 2002 Sep 19;347(12):886-94. doi: 10.1056/NEJMoa013390. N Engl J Med. 2002. PMID: 12239257 Free article.

9

Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G. Spurdle AB, et al. Among authors: hopper jl. Lancet. 2002 Sep 21;360(9337):925-6. doi: 10.1016/S0140-6736(02)11043-9. Lancet. 2002. PMID: 12354477

10

After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. Jenkins MA, et al. Among authors: hopper jl. Int J Cancer. 2002 Nov 10;102(2):166-71. doi: 10.1002/ijc.10670. Int J Cancer. 2002. PMID: 12385013 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,207 results

Search Page